Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Ovarian Cancer, Rare Gynecologic

Kathleen Moore

MD

🏢Stephenson Cancer Center, University of Oklahoma🌐USA

Jim and Christy Everest Endowed Chair in Cancer Research

75
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Kathleen Moore is a leading ovarian cancer clinical investigator who led the SOLO-1 maintenance olaparib trial and mirvetuximab soravtansine ADC development. She contributes to rare gynecologic tumor trials and serves in cooperative group leadership. Her work has changed practice in advanced ovarian cancer.

Share:

🧪Research Fields 研究领域

ovarian cancer
rare gynecologic tumors
antibody drug conjugates
PARP inhibitors
clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Kathleen Moore 的研究动态

Follow Kathleen Moore's research updates

留下邮箱,当我们发布与 Kathleen Moore(Stephenson Cancer Center, University of Oklahoma)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment